Masimo Corp (NASDAQ: MASI)

Masimo Corp, known by its ticker symbol MASI, is a global technology company operating in the healthcare and non-healthcare sectors. The company's main business activities revolve around developing, manufacturing, and marketing noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices, and consumer health products in the healthcare segment. In the non-healthcare segment, Masimo focuses on premium home sound integration technologies and accessories, as well as licensing high-performance in-vehicle audio systems under iconic consumer brands.

In the healthcare segment, Masimo's revenue is generated primarily through its product lines, including pulse oximetry, which enables noninvasive measurement of oxygen saturation levels in arterial blood. Masimo's pulse oximetry technology, Masimo SET, was designed to overcome the primary limitations of conventional pulse oximetry by maintaining accuracy in the presence of motion artifact, low perfusion, and weak signal-to-noise situations. The company's rainbow SET platform leverages Masimo SET technology and incorporates licensed rainbow technology to enable real-time monitoring of additional noninvasive measurements, such as hemoglobin species, perfusion index, and respiration rate. Masimo's patient monitoring and connectivity platforms, such as Root, provide multimodal monitoring and connectivity solutions in a single, clinician-centric platform.

Masimo's position within the industry is characterized by its technology leadership and innovative approach to patient monitoring. The company's Masimo SET technology is trusted by clinicians to safely monitor over 200 million patients each year, and has been chosen as the primary pulse oximeter technology used by nine of the top ten hospitals according to the 2022-2023 U.S. News & World Report Best Hospitals Honor Roll. Masimo's rainbow SET platform has also been widely adopted, with over 40 companies releasing rainbow SET-equipped products or announcing rainbow integration plans. Masimo's customers include hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities, and consumers.

Some of Masimo's key competitors in the pulse oximetry market include GE Healthcare, Hillrom, Mindray, Philips, Physio-Control, and Zoll. In the non-healthcare segment, Masimo competes with other premium home sound integration technology companies, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.

Masimo's competitive advantages include its technology leadership, innovative approach to patient monitoring, and strong relationships with its OEM partners and customers. The company's ability to expand its product offerings and market presence through strategic acquisitions, investments, and partnerships has also been a key factor in its success. In the non-healthcare segment, Masimo's premium home sound integration technologies and accessories, as well as licensing high-performance in-vehicle audio systems under iconic consumer brands, provide a competitive edge in the market.

In the healthcare segment, Masimo's product lines include Masimo SET, rainbow SET, Radical-7, Radius-7, Root, and Patient SafetyNet, among others. These products provide advanced monitoring and connectivity capabilities, including automated electronic charting of Masimo and third-party device data to patient data management systems. Masimo's non-healthcare segment includes products such as sound integration technologies and accessories, as well as licensing high-performance in-vehicle audio systems under iconic consumer brands.